Responsible Opioid Stewardship Across Populations: Optimizing Alternatives and Mitigating Risks
December 14th 2023To optimize patient safety, health care experts explore questions on assessment tools, monitoring strategies, specialty dosage forms, waste reduction, interdisciplinary collaboration, and responsible opioid prescribing practices.
Read More
The Emerging Role of Bispecific Antibodies in Diffuse Large B Cell Lymphoma Management
December 13th 2023Experts discuss the implementation, challenges, and safety measures of bispecific antibodies in lymphoma care, emphasizing multidisciplinary collaboration and patient access while navigating toxicity management.
Read More
Effective Implementation of Quality Care Programs for Patients With Myeloproliferative Neoplasms
April 16th 2022Pharmacy specialists discuss quality initiatives for myeloproliferative neoplasms, highlighting the importance of patient-specific, informative care in polycythemia vera, essential thrombocythemia, and myelofibrosis.
Read More
Best Practices for Prophylactic Therapy in Hemophilia A
June 23rd 2021A panel of experts discuss several topics pertaining to best practices and the challenges in regard to prophylaxis in hemophilia A, including the role of prophylaxis, prophylactic therapy options, outpatient care factors, and economic considerations.
Read More
Best Practices for Health-System Pharmacy During COVID-19
March 26th 2021Madeline Camejo, PharmD, MS, Michael Epshteyn, PharmD, MSM, and Estela Trimino, PharmD, BCPS, provide insights into the best practices implemented within their institutions by health-system pharmacy to address challenges brought on by COVID-19 related to infection control, treatment, and vaccine rollout.
Read More